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Background: This study examined outcomes of endovascular repair of infrarenal abdominal aortic aneurysms (EVAR)
using general, spinal, epidural, and local/monitored anesthesia care (MAC) in a multicenter North American hospital
database reflecting contemporary anesthesia and surgical practices.
Methods: Elective EVAR cases performed between 2005 and 2008 were identified from the American College of Surgeons
National Surgical Quality Improvement Program database using Current Procedural Terminology codes. Excluded were
emergency cases and patients with concomitant procedures requiring general anesthesia. Patient-level comorbidities,
characteristics, and intraoperative and postoperative details were examined. Complications were analyzed individually
and in aggregate categories, including wound, pulmonary, renal, venous thromboembolic, cardiovascular, operative, and
septic. Length of stay (LOS) and 30-day mortality were examined. Characteristics and outcomes were described using
mean standard deviation or count (%), and comparisons were evaluated for statistical significance using 2, Fisher exact
test, and univariate linear regression. LOS was analyzed with linear regression techniques using a log transformation.
Associations between anesthesia type and outcomes were examined using univariable and multivariable regression
techniques.
Results: We identified 6009 elective EVAR procedures for analysis. General anesthesia was used in 4868 cases, spinal
anesthesia in 419, epidural anesthesia in 331, and local/MAC in 391. Defined morbidity occurred in 11% of patients.
Median LOS was 2 (interquartile range, 1-3) days, and mean LOS was 2.8  4.3 days. The 30-day mortality rate was
1.1%. Significant multivariate associations were observed between anesthesia type, pulmonary morbidity, and log-LOS.
General anesthesia was associated with an increase in pulmonary morbidity vs spinal (odds ratio [OR], 4.0; 95%
confidence interval [CI], 1.3-12.5; P  .020) and local/MAC anesthesia (OR, 2.6; 95% CI, 1.0-6.4; P  .041). Use of
general anesthesia was associated with a 10% increase in LOS for general vs spinal anesthesia (95% CI, 4.8%-15.5%; P 
.001) and a 20% increase for general vs local/MAC anesthesia (95%CI, 14.1%-26.2%; P< .001). Trends toward increased
pulmonary morbidity and LOS were not observed for general vs epidural anesthesia. No significant association between
anesthesia type and mortality was observed.
Conclusions: In contemporary North American anesthetic and surgical practice, general anesthesia for EVAR was
associated with increased postoperative LOS and pulmonary morbidity compared with spinal and local/MAC anesthesia.
These data suggest that increasing the use of less-invasive anesthetic techniques may limit postoperative complications
and decrease the overall costs of EVAR. (J Vasc Surg 2011;54:1273-82.)
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doi:10.1016/j.jvs.2011.04.054Endovascular repair of abdominal aortic aneurysms
EVAR) was introduced in 1990 with the goal of offering
lower-risk alternative to traditional open surgical re-
air.1 Over time, EVAR has been proven to reduce
ertain classes of morbidity and hospital length of stay
LOS), with conflicting results regarding reductions in
arly-term and long-term mortality rates.2,3 Significant
ates of cardiac, renal, wound-related, and pulmonary
orbidity still occur with EVAR due to the relatively
igh-risk population inherent with aneurysmal disease of
he aorta.4 Surgical teams interested in minimizing these
omplications have sought to capitalize on the less-
nvasive nature of EVAR and limit perioperative morbid-
ty in several ways, including the use of alternative anes-
hesia strategies.
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November 20111274 Edwards et alVarious anesthetic techniques can be applied to suc-
cessfully accomplish EVAR, including general anesthesia,
regional anesthesia (including epidural and spinal anesthe-
sia), and local anesthesia, with or without monitored anes-
thesia care (MAC).5,6 Single-center and multicenter
reports have examined the results with these various anes-
thetic techniques for EVAR, with varying results.7-11 This
study examined the results of various anesthetic techniques
for EVAR in contemporary North American anesthetic and
surgical practice by using a large, multicenter data source,
the American College of Surgeons National Surgical Qual-
ity Improvement (ACS NSQIP) database.
METHODS
Data source. The ACS NSQIP is a validated, pro-
spective database derived from a systematic sampling of
cases at 211 participating hospitals throughout North
America. Available data include patient demographics,
medical risk factors, and detailed information regarding
procedural specifics and postoperative morbidity and
mortality. All data are collected at participating sites by
trained research nurses. Definitions for the variables
collected in the NSQIP database have been described in
previous reports.12-14
Study sample. Elective EVAR procedures performed
between January 2005 and December 2008 were identified
by querying the ACS NSQIP for cases with the use of
Current Procedural Terminology (CPT) codes (American
Medical Association, Chicago, Ill) for the deployment of
the main body of an endovascular aortic stent graft (CPT
codes 34800, 34802, 34803, 34804, 34805). The study
excluded cases coded as emergencies with International
Classification of Disease, 9th Edition code 441.3, which
designates a ruptured abdominal aortic aneurysm, cases
including codes for intraoperative open surgical conversion
(CPT codes 34830-34832), cases involving an iliac artery
exposure or conduit creation (CPT codes 34820 and
34833), and cases involving concomitant operative proce-
dures requiring general anesthesia. This was done to mini-
mize biases introduced from the analysis of cases in which
anesthetic choices were limited or crossovers occurred be-
tween anesthetic techniques, or both. This sampling strat-
egy resulted in the identification of 6009 elective EVAR
cases for analysis.
Demographics and medical risk factors. All demo-
graphic and medical risk factor data were extracted directly
from the ACS NSQIP database. Race was considered as
white or nonwhite (including Hispanic, Asian, Native
American, and black).
Age was considered as a continuous variable for the
purpose of this analysis. The ACS NSQIP public-use file
database contains a numeric age in years for all records
but codes all individuals aged 90 years as 90 years to
prevent the potential identification of individual patients
during analysis. In the study sample for this analysis, 110
of 6009 patients (1.8%) were coded as having an age of
90 years. sAmerican Society of Anesthesiology (ASA) classes were
onsidered as ASA category 1, 2, and 3 compared with ASA
lasses 4 and 5 in the multivariable models owing to the
elative paucity of patients in ASA classes 1, 2, and 5.
The estimated glomerular filtration rate (eGFR) was
sed to assess renal function and was calculated using the
bbreviated Modification of Diet in Renal Disease for-
ula.15 Body mass index (BMI) was calculated using
eight and height data (kg/m2). Operative time was de-
ned in the NSQIP data as the total operation time in
inutes.
Anesthesia type. Data regarding the type of anes-
hetic was extracted from the ACS NSQIP for all identified
lective EVAR cases. Anesthesia type was designated in the
CS NSQIP database as general, epidural, spinal, local,
AC, and other. All cases designated as “local” or “MAC”
ere combined (local/MAC) because some form of local
nalgesia is required for the EVAR procedure even in the
resence of centrally acting sedative and dissociative agents.
his analysis excluded 15 cases coded as “other,” one
oded as “none,” and 36 coded as “regional.”
End points. Three major outcomes were analyzed for
he purposes of this investigation: morbidity, mortality, and
ength of stay. Postoperative complications (morbidity)
ere analyzed individually, and in aggregate categories,
ncluding:
● wound: superficial or deep surgical site infections;
● pulmonary: pneumonia, reintubation, or failure to
wean from ventilator 48 hours from the end time of
the surgical procedure;
● renal: postoperative renal function decline or need for
dialysis;
● venous thromboembolic: deep vein thrombosis or pul-
monary embolism;
● cardiovascular: myocardial infarction, cardiac arrest, or
stroke;
● operative: return to operating room, postoperative
bleeding, or graft failure; and
● septic: sepsis and septic shock.
Postoperative mortality was defined as death 30 days
r during the same acute-care hospital stay, regardless of
ime. LOS was defined as the time from the EVAR proce-
ure to hospital discharge or death.
Statistical analysis. Preoperative characteristics, med-
cal risk factors, and procedural data were compared using
nivariate techniques, including 2 or Fisher exact tests for
ategoric variables and univariate linear regression or
ruskal-Wallis tests for continuous variables. Characteris-
ics are described usingmean standard deviation or count
%).
Morbidity and mortality associations were examined
sing logistic regression. LOS was log-transformed before
nalysis with linear regression to satisfy normality assump-
ions. Pairwise LOS comparisons were back-transformed
or presentation as percent differences.
All multivariable analyses were adjusted for age, race,
ex, current smoking status, and total work relative value
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Volume 54, Number 5 Edwards et al 1275units of the component CPT codes defining the surgical
procedure (to account for overall procedural complexity).
Additional covariates were included in the analyses of each
of the grouped morbidity classes as well as mortality. Co-
variates for the multivariable analyses were selected accord-
ing to previous full-sample analyses of the ACS NSQIP by
the central ACS NSQIP statistical faculty (which are avail-
able to each participating site) examining predictors of the
morbidity classes detailed above and mortality in vascular
surgery patients. The selected covariates for each analysis
are detailed in the tabulated results that follow in this
report. All analyses were performed using SAS 9.2 software
(SAS Institute, Cary, NC).
RESULTS
Study sample characteristics. Demographic and risk
factor data are summarized in Table I. We identified 6009
Table I. Patient characteristics by type of anesthesia durin
Ane
Elective EVAR Ge
Variablea (n  6009) (n 
Age, years 74.1  8.5 73.8
Nonwhite race 877 (14.6) 695
Female sex 982 (16.3) 779
Body mass index, kg/m2 28.0  5.6 28.1
Diabetes 862 (14.4) 707
Current smoker 1690 (28.1) 1400
Ever smoker 3794 (77.5) 3031
Functional status
Independent 5747 (95.6) 4668
Partially/totally dependent 262 (4.4) 200
History of
COPD 1104 (18.4) 885
Congestive heart failure 82 (1.4) 62
Myocardial infarction 70 (1.2) 65
Angina 132 (2.2) 100
Prior CABG 1461 (24.3) 1186
Prior PTCI 1265 (21.1) 1047
Hypertension 4758 (79.2) 3868
Revascularization or amputation 335 (5.6) 261
Dialysis dependencec 77 (1.3) 58
Transient ischemic attack 419 (7.0) 335
Stroke
No residual disability 280 (4.7) 232
Residual disability 299 (5.0) 244
Transfer status
Other hospital or facility 138 (2.3) 107
Admitted directly from home 5871 (97.7) 4761
ASA class
1-3 (no disturbance, mild, severe) 4914 (81.8) 3965
4-5 (life-threatening, moribund) 1093 (18.2) 901
eGFR (mL/min)d 68.6  23.0 68.9
Chronic dyspnea 1489 (24.8) 1197
ASA, American Society of Anesthesiologists; eGFR, estimated glomerular fi
coronary intervention.
aData are shown as mean  standard deviation or number (%).
bP values for overall tests of differences among the four anesthesia categories
for continuous variables.
cFisher exact test used in place of 2 (categoric). Dialysis indicated or creati
dSet to 0 for preoperative dialysis.elective EVAR cases. Types of anesthesia administered were seneral in 4868 cases (81%), spinal in 419 (7%), epidural in
31 (5.5%), and local/MAC in 391 (6.5%). The study
ample consisted of 5027 men (84%) and 982 women
16%), with a mean age of 74 years. Most patients (85%)
ere white.
Patient characteristics varied according to anesthesia
ype (Table I). Significant differences were observed ac-
ording to anesthesia type received in age, race, prior
istory of myocardial infarction, prior history of percutane-
us coronary revascularization, BMI, ASA class, and cur-
ent smoking. The mean values and prevalence of these
actors are summarized in Table I. Otherwise, comorbidi-
ies and risk factors were generally similar between the
nesthesia groups.
Procedural specifics. Procedural specifics are summa-
ized in Table II. The mean operative time for the study sample
as 158 minutes, with the surgeon designated as a vascular
ovascular aneurysm repair (EVAR)
a
Spinal Epidural Local/MAC
) (n  419) (n  331) (n  391) Pb
74.8  7.7 74.8  8.5 75.3  8.9 .0008
3) 86 (20.5) 32 (9.7) 64 (16.4) .0002
0) 71 (17.0) 61 (18.4) 71 (18.2) .4716
27.6  6.9 28.3  5.3 27.2  4.9 .0044
5) 62 (14.8) 38 (11.5) 55 (14.1) .4879
8) 125 (29.8) 74 (22.4) 91 (23.3) .0090
1) 289 (80.3) 239 (82.4) 235 (75.1) .0704
9) 394 (94.0) 318 (96.1) 367 (93.9) .0919
) 25 (6.0) 13 (3.9) 24 (6.1)
2) 69 (16.5) 65 (19.6) 85 (21.7) .2175
) 3 (0.7) 7 (2.1) 10 (2.6) .0680
) 1 (0.2) 0 4 (1.0) .0227c
) 9 (2.2) 7 (2.1) 16 (4.1) .0715
4) 99 (23.6) 88 (26.6) 88 (22.5) .6289
5) 83 (19.8) 49 (14.8) 86 (22.0) .0295
5) 334 (79.7) 246 (74.3) 310 (79.3) .1685
) 30 (7.2) 15 (4.5) 29 (7.4) .1314
) 8 (1.9) 5 (1.5) 6 (1.5) .5823
) 35 (8.4) 22 (6.7) 27 (6.9) .7172
) 19 (4.5) 14 (4.2) 15 (3.8) .8320
) 22 (5.3) 14 (4.2) 19 (4.9) .9229
) 12 (2.9) 9 (2.7) 10 (2.6) .7545
8) 407 (97.1) 322 (97.3) 381 (97.4)
5) 365 (87.1) 277 (83.7) 307 (78.5) .0078
5) 54 (12.9) 54 (16.3) 84 (21.5)
.0 68.2  23.3 66.6  23.0 67.8  23.3 .2683
6) 93 (22.2) 91 (27.5) 108 (27.6) .2038
n rate; MAC, monitored anesthesia care; PTCI, percutaneous transluminal
2 or Fisher exact test for categoric variables and one-way analysis of variance
vel 6.0 mg/dL.g end
sthesi
neral
4868
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November 20111276 Edwards et alof cases. The mean transfusion requirement was 2.3 units in the
11% of patients who required a transfusion. Most cases used
femoral artery access through a groin incision.
Procedural specifics varied according to anesthesia type
(Table II). Significant differences were observed according to
anesthesia type received in operative time, surgeon speciality,
involvement of a surgical resident, and the need for transfusion.
Associations with morbidity, mortality, and LOS.
Overall, defined morbidity occurred in 11% of patients,
median LOS was 2 days (interquartile range, 1-3 days), and
mean LOS was 2.8  4.3 days. The 30-day mortality rate
was 1.1%.
Rates of predefined end points are summarized in Table
III. Significant univariable differences were observed in
morbidity and LOS according to anesthesia type (Table
IV). Univariable associations were observed between gen-
eral anesthesia and an increase in any morbidity vs local/
MAC (P  .018), pulmonary morbidity vs spinal (P 
.010) and vs local/MAC (P  .042), and longer log-LOS
vs spinal (P  .001) and vs local/MAC (P  .001).
Multivariable analyses of morbidity, mortality, and
LOS are summarized in Table IV. Significant multivariable
differences were observed in morbidity and LOS according
to anesthesia type. Use of general anesthesia was associated
with a significant increase in pulmonary morbidity com-
pared with spinal (odds ratio [OR], 4.0; 95% confidence
interval [CI], 1.3-12.5; P  .020) and local/MAC anes-
Table II. Procedural specifics by type of anesthesia during
Anest
Elective EVAR Gene
Variablea (n  6009) (n  4
Surgeon speciality
Vascular surgeon 5868 (97.7) 4738 (
Cardiothoracic or general surgeon 141 (2.4) 130 (
Resident involved 3849 (64.2) 3050 (
Patients requiring transfusion 666 (11.1) 561 (
Units transfused (among those) 2.3  2.1 2.4 
Operative time (minutes) 157.5  67.2 159.7 
Access type
Percutaneousd 2661 (44.3) 2253 (
Any open femoral access 3348 (55.7) 2615 (
Single iliac or aortic extension 1666 (27.7) 1305 (
Multiple extensions 508 (8.5) 396 (
Hypogastric embolization 103 (1.7) 88 (
Endograft configuration
Bifurcated modular
One docking limb 2714 (45.2) 2165 (
Two docking limbs 2158 (35.9) 1741 (
Unibody bifurcated 441 (7.3) 364 (
Aorto-uni-iliac 257 (4.3) 209 (
Aortoaortic tube 480 (8.0) 422 (
Total work relative value units 38.7  14.8 38.3 
MAC, Monitored anesthesia care.
aContinuous variables are expressed as mean  standard deviation; categori
bP values for overall tests of differences among the four anesthesia categ
Kruskal-Wallis test for continuous variables.
cKruskal-Wallis test used in place of one-way analysis of variance (continuou
dDefined by absence of a femoral code.thesia (OR, 2.6; 95% CI, 1.0-6.4; P  .041). Other signif- tcant predictors of increased pulmonary morbidity included
urrent smoking, lower eGFR, ASA class 4 or 5, partial or
otal functional dependence, chronic obstructive pulmo-
ary disease (COPD), and the volume of any necessary
ransfusion. Complete multivariable model results for pul-
onary morbidity are presented in Table V (Hosmer-
emeshow goodness of fit; P  .05).
Use of general anesthesia was also significantly associ-
ted with a prolonged LOS, with a 10% increase for general
nesthesia compared with spinal (95% CI, 4.8%-15.5%; P
001) and a 20% increase for general anesthesia compared
ith local/MAC (95% CI, 14.1%-26.2%; P .001). Other
ignificant predictors of increased LOS included age, fe-
ale sex, nonwhite race, ASA class 4 or 5, percutaneous
emoral artery access, decreased eGFR, any level of func-
ional dependence other than independence; a history of
ongestive heart failure, COPD, angina, or diabetes; in-
reased volume of necessary transfusion, and operative
ime. Complete multivariable model results for LOS are
resented in Table VI.
Significant differences relative to general anesthesia
ere not observed for epidural anesthesia use with regard
o decreased pulmonary morbidity or LOS.
ISCUSSION
The anesthetic techniques used during EVAR varied
idely across North America, with general anesthesia being
ovascular aneurysm repair (EVAR)
Spinal Epidural Local/MAC
(n  419) (n  331) (n  391) Pb
417 (99.5) 330 (99.7) 383 (98.0) .0020
2 (0.5) 1 (0.3) 8 (2.1)
259 (62.4) 268 (81.5) 272 (69.7) .0001
24 (5.7) 38 (11.5) 43 (11.0) .0042
1.7  1.1 1.5  0.7 1.7  1.2 .0001c
8 137.4  53.1 156.5  58.4 152.1  63.4 .0001c
159 (38.0) 92 (27.8) 157 (40.2) .0001
260 (62.1) 239 (72.2) 234 (59.9)
127 (30.3) 93 (28.1) 141 (36.1) .0007
45 (10.7) 26 (7.9) 41 (10.5) .1266
4 (1.0) 8 (2.4) 3 (0.8) .1919
156 (37.2) 143 (43.2) 250 (63.9) .0001
192 (45.8) 144 (43.5) 81 (20.7) .0001
26 (6.2) 16 (4.8) 35 (9.0) .1399
19 (4.5) 17 (5.1) 12 (3.1) .5598
28 (6.7) 12 (3.6) 18 (4.6) .0003
8 41.2  13.4 39.9  12.8 40.8  16.8 .0001
bles as number (%).
from 2 test for categoric variables and one-way analysis of variance orend
hesia
ral
868)
97.3)
2.7)
62.8)
11.5)
2.2
68.
46.3)
53.7)
26.8)
8.1)
1.8)
44.5)
35.8)
7.5)
4.3)
8.7)
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Volume 54, Number 5 Edwards et al 1277observational study, the data presented suggest significant
advantages to the use of spinal and local/MAC anesthesia
compared with general anesthesia in the performance of
elective EVAR. In the examined sample of 6009 elective
EVAR cases from 211 North American hospitals from
2005 to 2008, the use of general anesthesia was associated
with higher postoperative pulmonary complications and
LOS than spinal and local/MAC anesthesia, even when
adjusting for other important patient characteristics.
EVAR was developed as a less-invasive and potentially
safer alternative to traditional open surgical repair for aortic
aneurysms.1 The most common surgical method for intro-
duction of the EVAR device is a groin incision, and no
aortic cross-clamping is required. As such, the procedure
lends itself to local and regional anesthesia techniques in a
way that open aneurysm repair does not. However, surgical
teams have yet to discern in which patients this advantage
can be most effectively used. Early reports from the inves-
tigational and European use of EVAR demonstrated the
feasibility of nongeneral anesthesia and suggested locore-
Table III. Outcomes by type of anesthesia during endova
Elective EVAR
Variablea (n  6009)
Morbidity (any of below) 677 (11.3)
Wound problems
Superficial wound infection 97 (1.6)
Deep wound infection 34 (0.6)
Organ space wound infection 3 (0.1)
Wound dehiscence 16 (0.3)
Any superficial or deep wound infection 130 (2.2)
Pulmonary
Pneumonia 73 (1.2)
Unplanned reintubation 99 (1.7)
Failure to wean from ventilator 75 (1.3)
Any pulmonary morbidity 168 (2.8)
Venous thromboembolic
Deep venous thrombosis 35 (0.6)
Pulmonary embolism 9 (0.2)
Genitourinary
Acute renal insufficiency 35 (0.6)
Acute renal failure 50 (0.8)
Urinary tract infection 99 (1.7)
Any renal insufficiency or renal failure 79 (1.3)
Cardiovascular
Stroke 27 (0.5)
Cardiac arrest 25 (0.4)
Myocardial infarction 15 (0.3)
Operative
Postoperative hemorrhage/transfusions 31 (0.5)
Graft failure 56 (0.9)
Return to operating room 260 (4.3)
Septic
Sepsis 62 (1.0)
Septic shock 53 (0.9)
Death 68 (1.1)
Post-op surgical length of stay, days 2.8  4.3
Length of stay, days 2 (1, 3)
MAC, Monitored anesthesia care.
aData are presented as mean  standard deviation, number (%), and mediangional anesthesia might have benefits. 4The first report describing the feasibility of local anes-
hesia for EVAR was published by Henretta et al6 in 1999.
hat report detailed no deaths or significant morbidity in a
eries of 47 consecutive patients. Also in 1999, Cao et al5
eported results in 115 patients undergoing EVAR, with 61
eceiving epidural anesthesia. Epidural anesthesia was asso-
iated with a reduction in the total hospital LOS and a
ower utilization of the intensive care unit (ICU) compared
ith general anesthesia.
The era of widespread American use of EVAR began in
999 after U.S. Food and Drug Administration (FDA)
pproval of the AneuRx (Medtronic, Minneapolis, Minn)
nd the Guidant EVT (Guidant Corp, Indianapolis, Ind)
evices for use. Since that time, other single-center reports
f EVAR using locoregional anesthesia techniques have
een published. In 2002, de Virgilio et al7 published a
eport demonstrating equivalent safety for local and general
nesthesia. However, their results demonstrated no differ-
nces in mortality, cardiac events, or pulmonary events in
n examination of 229 patients undergoing EVAR during a
r aneurysm repair (EVAR)
Anesthesia
General Spinal Epidural Local/MAC
(n  4868) (n  419) (n  331) (n  391)
567 (11.7) 37 (8.8) 43 (13.0) 30 (7.7)
84 (1.7) 8 (1.9) 4 (1.2) 1 (0.3)
31 (0.6) 2 (0.5) 0 1 (0.3)
1 (0.0) 0 1 (0.3) 1 (0.3)
15 (0.3) 0 1 (0.3) 0
115 (2.4) 9 (2.2) 4 (1.2) 2 (0.5)
67 (1.4) 2 (0.5) 3 (0.9) 1 (0.3)
91 (1.9) 0 4 (1.2) 4 (1.0)
71 (1.5) 1 (0.2) 2 (0.6) 1 (0.3)
155 (3.2) 3 (0.7) 5 (1.5) 5 (1.3)
30 (0.6) 1 (0.2) 3 (0.9) 1 (0.3)
8 (0.2) 0 1 (0.3) 0
29 (0.6) 2 (0.5) 3 (0.9) 1 (0.3)
46 (0.9) 1 (0.2) 2 (0.6) 1 (0.3)
81 (1.7) 8 (1.9) 5 (1.5) 5 (1.3)
69 (1.4) 3 (0.7) 5 (1.5) 2 (0.5)
21 (0.4) 2 (0.5) 1 (0.3) 3 (0.8)
20 (0.4) 1 (0.2) 2 (0.6) 2 (0.5)
14 (0.3) 0 1 (0.3) 0
26 (0.5) 1 (0.2) 3 (0.9) 1 (0.3)
45 (0.9) 2 (0.5) 5 (1.5) 4 (1.0)
214 (4.4) 13 (3.1) 18 (5.4) 15 (3.8)
49 (1.0) 6 (1.4) 6 (1.8) 1 (0.3)
46 (0.9) 1 (0.2) 3 (0.9) 3 (0.8)
60 (1.2) 1 (0.2) 4 (1.2) 3 (0.8)
2.9  4.2 2.1  1.8 2.7  5.1 2.3  6.1
2 (1, 3) 1 (1, 2) 2 (1, 3) 1 (1, 2)
rquartile range).scula-year period. In 2005, Verhoeven et al11 reported that the
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November 20111278 Edwards et aluse of primary local anesthesia was safe and associated with
improvements in pulmonary morbidity and decreased ICU
stay.
These single-center, retrospective reports demon-
strated the safety of locoregional anesthetic techniques for
EVAR compared with general anesthesia; furthermore, all
but one suggested that significant benefits might be asso-
ciated with these techniques. The studies were limited,
however, because they reflected single-center practice pat-
terns and included a relatively small number of patients in
their analyses.
Larger multicenter observational studies of these issues
have also been reported. Parra et al8 reported associations
among EVAR performed under local anesthesia with de-
creased LOS and a decrease in a variety of morbid events
(including renal, wound, and cardiac complications) in a
retrospective analysis of 424 patients undergoing EVAR as
part of a phase II trial of the AneuRx device (Medtronic).
Table IV. Regression model results for anesthesia groups
Overall
anesthesia General vs spinal
Outcomes P OR (95% CI)
Renal morbidityb
Unadjusted .3398
Multivariable modelc .2803
Pulmonary morbidityb
Unadjusted .0047 4.6 (1.5-14.4) .0
Multivariable modeld .0126 4.0 (1.3- 12.5) .0
Mortalityb
Unadjusted .3536
Multivariable modele .3463
Wound morbidityb
Unadjusted .0958
Multivariable modelf .1403
Any morbidityb
Unadjusted .0279 1.4 (1.0-1.9) .0
Multivariable modelg .0514
% Difference (95% CI) P
Length of stayh
Unadjusted .0001 16.80 (10.8-23.1) .0
Multivariable modelg .0001 10.00 (4.8-15.5) .0
CI, Confidence interval; MAC, monitored anesthesia care; OR, odds ratio.
aP value for contrast.
bLogistic regression.
cModel covariates for renal: age, gender, race, current smoker, total work
estimated glomerular filtration rate, functional status, body mass index, diab
dModel covariates for pulmonary: age, gender, race, current smoker, total wo
estimated glomerular filtration rate, functional status, history of congestiv
accident; red blood cell transfusions, dyspnea.
eModel covariates for mortality: age, gender, race, current smoker, total wor
estimated glomerular filtration rate functional status, body mass index; his
cerebrovascular accident; red blood cell transfusions, prior percutaneous tra
fModel covariates for wound: age, gender, race, current smoker, total work
obstructive pulmonary disease, operative time, long-term steroid use.
gModel covariates for any morbidity and length of stay: age, gender, race, cu
Anesthesiologists class, estimated glomerular filtration rate, functional status
pulmonary disease, angina, cerebrovascular accident; red blood cell transfus
hLinear regression (log-transformed for analysis, back-transformed results aMore recently, investigators have used the European Col- waborators on Stent-Graft Techniques for Aortic Aneurysm
epair (EUROSTAR) registry of EVAR procedures to
xamine issues of anesthesia type and outcome. In an initial
nalysis of 5557 patients undergoing EVAR, Ruppert et al9
eported decreased ICU admissions, LOS, and cardiac
omplications in multivariable analyses of locoregional an-
sthesia techniques. In that report, the greatest reductions
ere seen with local anesthesia techniques for EVAR.
The same group reported additional analyses of the
UROSTAR data in 2007 with patients stratified into
igh-risk and low-risk categories according to ASA class.10
n that stratified analysis, the most significant benefits from
ocal and regional anesthesia were seen in patients desig-
ated as high risk. Decreased ICU utilization was observed
ith local anesthesia and decreased early mortality was
bserved with regional anesthesia in high-risk patients.
ther than this latter analysis of high-risk patients, none of
hese studies have demonstrated any effect on mortality
orbidity and mortality outcomes
General vs epidural General vs MAC/local
OR (95% CI) Pa OR (95% CI) Pa
2.1 (0.9-5.3) .0958 2.5 (1.0-6.2) .0417
1.9 (0.8-4.7) .1711 2.6 (1.0-6.4) .0409
0.9 (0.6-1.2) .4626 1.6 (1.1-2.3) .0181
% Difference (95% CI) P % Difference (95% CI) P
5.20 (–0.9 to 11.6) .0945 20.10 (13.7-26.9) .0001
3.60 (–1.9 to 9.4) .2046 20.00 (14.1-26.2) .0001
e value units, femoral access, American Society of Anesthesiologists class,
hypertension, history of congestive heart failure.
tive value units, femoral access, American Society of Anesthesiologists class,
rt failure, chronic obstructive pulmonary disease, angina, cerebrovascular
ive value units, femoral access, American Society of Anesthesiologists class,
f congestive heart failure, chronic obstructive pulmonary disease, angina,
inal coronary intervention, prior coronary artery bypass grafting.
e value units, femoral access, body mass index, diabetes, history of chronic
smoker, total work relative value units, femoral access, American Society of
mass index, diabetes; history of congestive heart failure, chronic obstructive
perative time.
ented).vs m
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previously referenced findings. Our analysis showed the use
of local/MAC and spinal anesthesia was associated with a
significant decrease in pulmonary complications compared
with general anesthesia in multivariable models adjusting
for pertinent risk factors. Further, a decreased LOS was also
seen favoring the use of local/MAC and spinal anesthesia.
Significant associations relative to general anesthesia were
not observed for epidural anesthesia. These findings were
Table V. Complete multivariable logistic regression result
Variable
General anesthesia vs
Spinal
Epidural
Monitored anesthesia care/local
Age, years
Female
Nonwhite
Current smoker
Total work relative value units
Access (percutaneous vs femoral)
ASA class (4-5 vs 1-3)
Estimated glomerular filtration rate
Functionally dependent (partial/total vs independent)
History of
Congestive heart failure
Congestive obstructive pulmonary disease
Angina
Cerebrovascular accident
Units transfused
Chronic dyspnea
ASA, American Society of Anesthesiologists; CI, confidence interval; OR, o
Table VI. Multivariable linear regression results for log-le
Variable
General anesthesia vs
Spinal
Epidural
Monitored anesthesia care/local
Age, years
Female
Nonwhite
Current smoker
Total work relative value units
Access (percutaneous vs femoral)
ASA class (4-5 vs 1-3)
Estimated glomerular filtration rate
Functionally dependent (partial/total vs independent)
Body mass index
History of
Congestive heart failure
Diabetes
Congestive obstructive pulmonary disease
Angina
Cerebrovascular accident
Units transfused
Operative time, min
ASA, American Society of Anesthesiologists; CI, confidence interval.observed in a large sample of EVAR cases sampled from Eontemporary medical practice in North American hospi-
als and provide a “real-world” description of both the use
f less-invasive anesthetic techniques and the relative value
f those techniques in limiting morbidity.
The EUROSTAR registry findings are quite similar to
hose reported here. Health systems in Europe, however,
ossess features that are quite different from the system in
he United States, which may limit the applicability of their
ndings to American medical practice. In the initial
pulmonary morbidity
OR (95% CI) P
.0126
3.96 (1.25-12.54) .0195
1.89 (0.76-4.73) .1711
2.58 (1.04-6.41) .0409
1.01 (0.99-1.03) .5297
1.14 (0.77-1.69) .5139
1.47 (0.98-2.21) .0663
1.55 (1.07-2.23) .0197
1.00 (0.99-1.01) .9202
1.48 (1.0-2.18) .0504
1.50 (1.04-2.16) .0287
0.99 (0.98-0.99) .0004
2.09 (1.23-3.56) .0064
1.93 (0.85-4.40) .1164
1.71 (1.16-2.53) .0069
1.35 (0.56-3.28) .5050
0.92 (0.56-1.52) .7394
1.32 (1.22-1.43) .0001
1.13 (0.77-1.65) .5416
tio.
of stay
 (95% CI) P
.0001
0.095 (0.046-0.144) .0001
0.035 (–0.019 to 0.090) .2046
0.182 (0.132-0.232) .0001
0.003 (0.002-0.005) .0001
0.101 (0.067-0.136) .0001
0.075 (0.040-0.111) .0001
0.008 (–0.023 to 0.037) .6608
0.000 (–0.001 to 0.001) .7934
0.030 (0.000 0.060) .0495
0.100 (0.068-0.133) .0001
–0.002 (–0.002 to –0.001) .0001
0.285 (0.223-0.347) .0001
–0.001 (–0.004 to 0.001) .2725
0.294 (0.187-0.402) .0001
0.040 (0.005-0.076) .0259
0.072 (0.040-0.105) .0001
0.121 (0.037-0.205) .0048
0.037 (–0.005 to 0.079) .0867
0.085 (0.071-0.099) .0001
0.002 (0.0017-0.0021) .0001s forngthUROSTAR report by Ruppert et al,9 the average LOS
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EVAR observed in this report. This likely represents a
greater caution toward discharge in the early days of EVAR,
because EUROSTAR contains data from 1997 to 2004,
and the ACS NSQIP contains data from 2005 to 2008. In
addition, the devices available for use in European coun-
tries also differ from those approved by the FDA. Further-
more, the relative availability of EVAR to the general
patient population in Europe relative to North America
may differ because of differences in the respective health
care delivery systems, which limit (and in some cases pro-
hibit) EVAR or other surgical procedures in high-risk or
elderly European patients. To this point, the high-risk
patients described in Ruppert et al10 described all patients
with ASA class3 as high risk, which would have included
93% of the study sample for this report.
European biases toward a more aggressive use of less-
invasive anesthesia also likely play a role in the differences in
outcomes among European and American studies. These
differences are demonstrated in the distributions of general,
regional, and local anesthesia reported in EUROSTAR
(69%, 25%, and 6%) and the ACS NSQIP (81%, 13%, and
6%). The sum of these differences is significant. As such,
this study represents the first large-scale demonstration of
locoregional anesthetic benefit from American sources us-
ing contemporary technology.
As a separate concern, most of the preceding data
presented regarding the benefits of using regional anesthe-
sia have been derived from the use of epidural anesthesia.
This report demonstrates clear benefits from the use of
local/MAC and spinal anesthesia, but not epidural anesthe-
sia, especially in relation to LOS. This finding is clearly
different from the results of the preceding single-center and
multicenter data presented and represents a unique and
intriguing finding. The observed lack of significant associ-
ations between epidural anesthesia and decreased pulmo-
narymorbidity or LOS could have been due to the effects of
local anesthetic or adjuvant agents commonly used within
epidural anesthetics. The volume and concentration of
local anesthetics affects epidural dermatomal spread as well
as the depth of analgesia or the degree of motor blockade,
or both. When patients are supine, cephalad spread of local
anesthetics or epidural narcotics to the midthoracic or
lower cervical regions during a continued infusion may
impair pulmonary mechanics, thus increasing the risk of
postoperative pulmonary dysfunction and LOS. Narcotic
adjuvants are also frequently added to local anesthetic
epidural infusions. These agents also have the potential to
centrally suppress respiratory drive and thereby affect rates
of reintubation and LOS.
Potential mechanisms by which locoregional anesthesia
may affect the morbidity of EVAR include avoidance of
endotracheal intubation and mechanical ventilation as well
as the potential for residual neuromuscular paralysis after
reversal. Atelectasis ensues immediately after induction of
general anesthesia and persists well into the postoperative
phase.16,17 Positive pressure ventilation results in atelecta-
sis, diminishes functional residual capacity, and increases ohe risk of reintubation, especially in the elderly.18 High-
isk patients (ASA 4 and 5 and elderly) are at a greater risk
f postoperative pulmonary morbidity with general anes-
hesia, even after what appears to be adequate reversal of
euromuscular blockade. Furthermore, general anesthesia
requently involves the use of volatile anesthetics during the
aintenance phase. Inhalational agents have been associ-
ted with immunosuppression, potentially increasing the
isk of postoperative pneumonia in the setting of atelectasis,
iminished cough reflex, or in patients at risk for aspira-
ion.19,20
Locoregional anesthesia avoids mechanical ventilation
nd permits maintenance of spontaneous ventilation,
hereby minimizing the patient’s exposure to factors that
ncrease the risk of postoperative pulmonary failure. Fur-
hermore, locoregional anesthetic techniques provide pre-
mptive analgesia and improve postoperative pain control
elative to general anesthesia alone, which may reduce the
ncidence of hypertension and tachycardia related to surgi-
al stress and postoperative pain. Locoregional techniques
lso allow for avoidance of ventilator weaning at the end of
nesthesia, which can be challenging in compromised pa-
ients.
Our study showed that local/MAC and spinal anesthe-
ia techniques were able to reduce LOS by 10% to 20%,
ven in the context of the shorter observed American
ospital LOS. These anesthetic techniques were also asso-
iated with a 60% to 75% decrease in the odds of postoper-
tive pulmonary complications, including pneumonia and
ailure to wean from the ventilator 48 hours of surgery.
hese complications obviously increase patient discomfort
nd commonly require admission to the ICU or extension
f the ICU stay. Given the high estimated cost of such
osocomial pneumonias ($12,000 per occurrence21) and
he potential savings of the observed decreases in LOS, the
ignificance of these data to contemporary American health
are is obvious.
An obvious explanation, however, is not apparent for
he differences in spinal and epidural anesthesia in their
bserved advantages relative to general anesthesia in the
erformance of EVAR. It is possible that the smaller sample
eceiving epidural anesthesia resulted in the lack of a signif-
cant association, which would be suggested by the ob-
erved trends toward an association (especially with regard
o pulmonary complications). Plausible mechanisms can be
ut forth, though, to explain the observed differences. In
ddition to the potential mechanisms underlying the lack of
n observed association discussed above, it is also possible
hat epidural anesthesia was associated with increased crys-
alloid fluid administration due to prolonged sympatholysis
elative to spinal anesthesia and that this fluid volume was
ssociated with a slightly higher rate of pulmonary compli-
ation (and accordingly LOS). It is also possible that epi-
ural anesthetics were associated with a small but signifi-
ant incidence of complications found with the more
omplicated technique involving catheter placement (ie,
ostepidural headache), which may also have resulted in
ccasional increases in LOS. Unfortunately, the data points
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be addressed.
This study possesses a number of other limitations that
deserve comment. As with almost all secondary analyses of
existing databases, the database was not specifically de-
signed to assess the question of interest. The ACSNSQIP is
a quality-of-care tool that is not optimized to assess specif-
ics of endovascular surgical and anesthetic care. Detailed
data regarding patient anatomy, device selection, anesthetic
techniques, monitoring, or conversion between anesthetic
techniques were not collected and cannot be analyzed.
Patients were also not randomized to their anesthesia
type, eliminating any control for known (or unknown)
confounding factors. Individual anesthetic selections were
made according to surgeon and anesthesiologist prefer-
ence, incorporating the biases of those individuals as well as
patient-specific factors such as anatomy, medical risk, avail-
able resources, and procedural complexity. As such, this
report represents a large, uncontrolled investigation of
anesthetic technique as it was applied in contemporary
medical practice and was not a test of an a priori hypothesis.
Furthermore, data were also lacking for analysis regard-
ing surgeon and institutional identity. This raises the pos-
sibility that the biases of individuals and institutions and the
potential for unbalanced confounding factors in the ab-
sence of randomization, such as the observed tendency for
general anesthesia for longer (and presumably more com-
plex) cases, may have produced the observed differences.
The likelihood, though, of such a type I error is mitigated
somewhat by the use of multivariable methods to control
for potential confounding factors as identified by univari-
able analyses of these data and prior analyses of morbidity
and mortality in vascular surgery patients throughout the
ACS NSQIP.
It is also possible that other missing data points such as
the time of surgery, the day of the week of surgery, and
urinary retention affected our findings, especially with re-
gard to LOS. Further mitigation of unmeasured confound-
ing would require more detailed data or advanced observa-
tional methods, such as propensity score modeling,
hierarchical modeling, or instrumental variable analysis. In
the analysis we have described, implementation of these
methods is limited by the relatively small number of pa-
tients in each exposure category, as well as by the relatively
small proportion of high-risk pulmonary patients.
CONCLUSIONS
This study represents a large-sample investigation of
the benefits and liabilities of differing anesthesia types in the
performance of EVAR in North America using contempo-
rary anesthetic and surgical techniques. The results suggest
that the use of general anesthesia for the performance of
EVAR is associated with higher rates of pulmonary morbid-
ity and a 10% to 20% increase in LOS relative to locore-
gional anesthetic techniques, specifically local/MAC and
spinal anesthesia. These data support an increase in the use
of local anesthesia/MAC or spinal anesthesia in EVARatients suitable for such anesthetic approaches to reduce
ulmonary morbidity and length of stay.
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